Roche Is Latest MNC To Partner A Primary Care Product In Korea
This article was originally published in PharmAsia News
Handok, which is partially owned by Sanofi, will sell Roche’s Madopar for Parkinson’s disease in Korea.
You may also be interested in...
SEOUL - South Korean local pharmas Hanlim Pharm, Daewoong Pharmaceutical and Pacific Pharma are gearing up to sell an incrementally modified version of Actonel (risendronate), which was originally developed by Sanofi-Aventis and has been sold in Korea by local firm Handok Pharmaceuticals
SEOUL - The Korea Food & Drug Administration granted approval to local South Korean Chong Kun Dang Pharmaceutical to sell its generic version of Roche's Tamiflu (oseltamivir) at some point in the future
SEOUL - Novartis Korea's DPP-4 inhibitor type 2 diabetes treatment Galvus (vildagliptin) will be covered by South Korea's National Health Insurance Policy beginning Feb. 1 for second-line treatment